ISRCTN81818883已完成未知
Double-blind, randomised, placebo-controlled pilot study of LC in systemic lupus erythematosus
Department of Health (Taiwan) - Executive Yuan0 个研究点目标入组 90 人开始时间: 2008年4月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients fulfill the revised American College of Rheumatology (ACR) criteria for systemic lupus erythematosus (SLE)
- •2. Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score more than or equal to 2 and less than or equal to 36
- •3. Daily dose of prednisolone less than or equal to 0.6 mg/kg
- •4. Age more than or equal to 7 years old and body weight more than or equal to 40 kg, either sex
排除标准
- •1. Alcoholism
- •2. Diabetes mellitus
- •3. Life-threatening disease
- •4. Pregnant or nursing women
- •5. Creatinine clearance less than or equal to 25 cc/min
- •6. Aspartate aminotransferase (AST), alanine aminotransferase (ALT) more than or equal to 2 x normal limit
研究者
相似试验
已完成
不适用
A pilot study of D-cycloserine-augmented cognitive behavioural therapy (CBT) with exposure therapy in adolescents with obsessive-compulsive disorder (OCD)Mental and Behavioural DisordersObsessive-compulsive disorderISRCTN70977225Institute of Psychiatry, Kings College London (UK)24
进行中（未招募）
1 期
A randomised double-blind placebo-controlled pilot study of D-cycloserine-augmented exposure therapy in adolescents with obsessive-compulsive disorderEUCTR2008-006947-38-GBKing's College London (Institute of Pyschiatry)24
进行中（未招募）
1 期
A pilot study of the use of metformin to reduce airway glucose in COPDChronic obstructive pulmonary diseaseMedDRA version: 21.1 Level: LLT Classification code 10010952 Term: COPD System Organ Class: 100000004855EUCTR2018-001755-12-GBImperial College40
进行中（未招募）
1 期
Double-blind, cross-over, placebo-controlled pilot study to characterize the profile of those patients with traumatic spinal cord injury diagnosed by electrophysiological, urodynamic and clinical (ASIA group) assesment who may respond to vardenafil treatment. - LEMDEErectile dysfunction (ED)EUCTR2004-005282-37-ESQUIMICA FARMACEUTICA BAYER, S.A.
已完成
Unknown
A pilot randomized, double-blind, placebo-controlled, parallel-group clinical study to study the safety and tolerability of IP in healthy adultsCTRI/2023/03/050853Vedic Lifesciences Pvt Ltd64